Edwin Torr
Directeur/Membre du Conseil chez ANIMALCARE GROUP PLC
Fortune : 312 156 $ au 30/04/2024
Profil
Edwin Thomas Torr is currently a Senior Independent Non-Executive Director at Animalcare Group Plc and an Independent Non-Executive Director at Intervacc AB.
Previously, he was the Chairman of Agrimin Ltd.
and held positions at Dechra Pharmaceuticals Plc and Dechra Veterinary Products Ltd., including Director of Business Development and Managing Director, respectively.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
ANIMALCARE GROUP PLC
0,18% | 31/12/2022 | 107 455 ( 0,18% ) | 312 156 $ | 30/04/2024 |
Postes actifs de Edwin Torr
Sociétés | Poste | Début |
---|---|---|
ANIMALCARE GROUP PLC | Directeur/Membre du Conseil | 13/07/2017 |
INTERVACC AB | Directeur/Membre du Conseil | 01/03/2020 |
Anciens postes connus de Edwin Torr
Sociétés | Poste | Fin |
---|---|---|
DECHRA PHARMACEUTICALS | Directeur/Membre du Conseil | 01/01/2013 |
Dechra Veterinary Products Ltd.
Dechra Veterinary Products Ltd. Pharmaceuticals: MajorHealth Technology Dechra Veterinary Products Ltd. engages in the development of branded pharmaceuticals for companion animals. The company is headquartered in Shrewsbury, the United Kingdom. | Directeur Général | 01/09/2000 |
AGRIMIN LIMITED | Président | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
ANIMALCARE GROUP PLC | Health Technology |
INTERVACC AB | Health Technology |
AGRIMIN LIMITED | Non-Energy Minerals |
Entreprise privées | 2 |
---|---|
Dechra Pharmaceuticals Plc
Dechra Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Dechra Pharmaceuticals Ltd. is a holding company, which engages in the veterinary pharmaceuticals and related products business. It operates through the following segments: European Pharmaceuticals; North American Pharmaceuticals; and Pharmaceuticals Research and Development. The European Pharmaceuticals segment markets and sells licensed pharmaceuticals and specialist pet foods to the veterinary profession in Europe. The North American Pharmaceuticals segment focuses on the sale of a range of endocrine, ophthalmic, dermatological, and equine products in North America. The Pharmaceuticals Research and Development segment develops and licenses Dechra's own branded veterinary product portfolio of novel and generic pharmaceuticals and specialist pet diets. The company was founded in 1819 and is headquartered in Northwich, the United Kingdom. | Health Technology |
Dechra Veterinary Products Ltd.
Dechra Veterinary Products Ltd. Pharmaceuticals: MajorHealth Technology Dechra Veterinary Products Ltd. engages in the development of branded pharmaceuticals for companion animals. The company is headquartered in Shrewsbury, the United Kingdom. | Health Technology |